Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION - (Details)

v3.23.3
SHARE-BASED COMPENSATION - (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2023
Feb. 28, 2023
Apr. 30, 2022
Jan. 31, 2022
Jul. 31, 2021
Jun. 30, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Apr. 30, 2021
Share-based compensation                      
Stock options granted (in shares)                 517,500    
Grant exercise price (in dollars per share)                 $ 3.35    
Total compensation expense not yet recognized             $ 3,292,136   $ 3,292,136    
Weighted average vesting period                 1 year 5 months 15 days    
Intrinsic value of stock option             0   $ 0    
Weighted average contractual life                 8 years 21 days    
June 2021                      
Share-based compensation                      
Share based compensation expense             181,720 $ 181,720 $ 545,160 $ 545,160  
Common stock shares available (in shares)           807,500          
Grant exercise price (in dollars per share)           $ 6.26          
June 2021 | Employee | Tranche one                      
Share-based compensation                      
Vesting percentage           40.00%          
June 2021 | Employee | Tranche two                      
Share-based compensation                      
Vesting term of options           36 months          
July 2021                      
Share-based compensation                      
Share based compensation expense             490,916 490,916 1,472,750 1,472,750  
Stock options granted (in shares)         1,550,000            
Grant exercise price (in dollars per share)         $ 6.18            
July 2021 | Executive officers | Tranche one                      
Share-based compensation                      
Vesting percentage         25.00%            
July 2021 | Executive officers | Tranche two                      
Share-based compensation                      
Vesting term of options         36 months            
July 2021 | Independent Directors, Consultant                      
Share-based compensation                      
Vesting term of options         36 months            
January 2022                      
Share-based compensation                      
Share based compensation expense             18,950 18,950 56,850 126,333  
Stock options granted (in shares)       80,000              
Grant exercise price (in dollars per share)       $ 4.44              
January 2022 | Tranche one                      
Share-based compensation                      
Vesting percentage       25.00%              
January 2022 | Tranche two                      
Share-based compensation                      
Vesting term of options       36 months              
April 2022                      
Share-based compensation                      
Share based compensation expense             5,378 $ 5,378 16,133 $ 30,473  
Stock options granted (in shares)     30,000                
Grant exercise price (in dollars per share)     $ 3.79                
April 2022 | Tranche one                      
Share-based compensation                      
Vesting percentage     25.00%                
April 2022 | Tranche two                      
Share-based compensation                      
Vesting term of options     36 months                
February 2023                      
Share-based compensation                      
Share based compensation expense             109,521   255,549    
Stock options granted (in shares)   467,500                  
Grant exercise price (in dollars per share)   $ 3.41                  
Vesting term of options   36 months                  
June 2023                      
Share-based compensation                      
Share based compensation expense             $ 26,800   $ 26,800    
Stock options granted (in shares) 50,000                    
Grant exercise price (in dollars per share) $ 2.75                    
Vesting term of options 1 year                    
2021 Equity Incentive Plan                      
Share-based compensation                      
Common stock shares reserved                     2,874,063
Common stock shares available (in shares)             485,868   485,868